Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Depreciation & Amortization (CF): 2010-2021

Historic Depreciation & Amortization (CF) for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2021 value amounting to $3.0 million.

  • Neurocrine Biosciences' Depreciation & Amortization (CF) rose 36.36% to $3.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $10.9 million, marking a year-over-year increase of 26.74%. This contributed to the annual value of $23.5 million for FY2024, which is 32.02% up from last year.
  • Neurocrine Biosciences' Depreciation & Amortization (CF) amounted to $3.0 million in Q4 2021, which was up 7.14% from $2.8 million recorded in Q3 2021.
  • Neurocrine Biosciences' Depreciation & Amortization (CF)'s 5-year high stood at $3.0 million during Q4 2021, with a 5-year trough of $489,000 in Q1 2017.
  • Its 3-year average for Depreciation & Amortization (CF) is $2.2 million, with a median of $2.1 million in 2020.
  • Data for Neurocrine Biosciences' Depreciation & Amortization (CF) shows a peak YoY skyrocketed of 102.27% (in 2019) over the last 5 years.
  • Over the past 5 years, Neurocrine Biosciences' Depreciation & Amortization (CF) (Quarterly) stood at $706,000 in 2017, then spiked by 80.59% to $1.3 million in 2018, then soared by 56.86% to $2.0 million in 2019, then rose by 10.00% to $2.2 million in 2020, then spiked by 36.36% to $3.0 million in 2021.
  • Its last three reported values are $3.0 million in Q4 2021, $2.8 million for Q3 2021, and $2.6 million during Q2 2021.